Relation between Ocular Comfort, Arachidonic Acid Mediators, and Histamine

References

• Nichols KK, Redfern RL, Jacob JT, Nelson JD, Fonn D, Forstot SL, et al. The TFOS International Workshop on Contact Lens Discomfort: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 2013; 54:TFOS14–TFOS19.
   Web of Science ®Google Scholar
• Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea 2007;26:168–174.
   PubMed Web of Science ®Google Scholar
• Guillon M, Maissa C. Dry eye symptomatology of soft contact lens wearers and nonwearers. Optom Vis Sci 2005;82:829–834.
   PubMed Web of Science ®Google Scholar
• Young G, Veys J, Pritchard N, Coleman S. A multi-centre study of lapsed contact lens wearers. Ophthalmic Physiol Opt 2002;22:516–527.
   PubMed Web of Science ®Google Scholar
• Efron N, Jones L, Bron AJ, Knop E, Arita R, Barabino S, et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci 2013; 54:TFOS98–TFOS122.
   PubMed Web of Science ®Google Scholar
• Craig JP, Willcox MD, Argueso P, Maissa C, Stahl U, Tomlinson A, et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the tear film subcommittee. Invest Ophthalmol Vis Sci 2013; 54:TFOS123–TFOS156.
   Web of Science ®Google Scholar
• Young G, Keir N, Hunt C, Woods CA. Clinical evaluation of long-term users of two contact lens care preservative systems. Eye Contact Lens 2009;35:50–58.
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871–1875.
   PubMed Web of Science ®Google Scholar
• Ambache N, Brummer HC. A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts. Br J Pharmacol Chemother 1968;33:162–170.
   Web of Science ®Google Scholar
• Van Horn DL, Sendele DD, Seideman S, Buco PJ. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci 1977;16:597–613.
   PubMed Web of Science ®Google Scholar
• Narumiya S, FitzGerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 2001;108:25–30.
   PubMed Web of Science ®Google Scholar
• Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001;108:15–23.
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Narumiya S, Ichikawa A. Distribution and function of prostanoid receptors: studies from knockout mice. Prog Lipid Res 2000;39:289–314.
   PubMed Web of Science ®Google Scholar
• Shim J, Park C, Lee HS, Park MS, Lim HT, Chauhan S, et al. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology 2012;119:2211–2219.
   PubMed Web of Science ®Google Scholar
• Woodward DF, Nieves AL, Williams LS, Gary RK, Jr., Wasserman MA, Gleason JG. Interactive effects of peptidoleukotrienes and histamine on microvascular permeability and their involvement in experimental cutaneous and conjunctival immediate hypersensitivity. Eur J Pharmacol 1989;164:323–333.
   PubMed Web of Science ®Google Scholar
• Bhattacherjee P. The role of arachidonate metabolites in ocular inflammation. Prog Clin Biol Res 1989;312:211–227.
   PubMedGoogle Scholar
• Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006;36:689–703.
   PubMed Web of Science ®Google Scholar
• Mantelli F, Calder VL, Bonini S. The anti-inflammatory effects of therapies for ocular allergy. J Ocul Pharmacol Ther 2013;29:786–793.
   PubMed Web of Science ®Google Scholar
• Tan M, Thakur A, Morris C, Willcox MD. Presence of inflammatory mediators in the tears of contact lens wearers and non-contact lens wearers. Aust N Z J Ophthalmol 1997;25 Suppl 1:S27–S29.
   PubMedGoogle Scholar
• Thakur A, Willcox MD, Stapleton F. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. J Clin Immunol 1998;18:61–70.
   PubMed Web of Science ®Google Scholar
• Yamada M, Ogata M, Kawai M, Mochizuki H, Mashima Y. Topical diclofenac sodium decreases the substance P content of tears. Arch Ophthalmol 2002;120:51–54.
   PubMedGoogle Scholar
• Masoudi S, Zhao Z, Stapleton F, Willcox M. Contact lens-induced discomfort and inflammatory mediator changes in tears. Eye Contact Lens 2016; in press. DOI: 10.1097/ICL.0000000000000237.
   Web of Science ®Google Scholar
• Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 2009;49:123–150.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 2015;7:a016311.
   Web of Science ®Google Scholar
• Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025–1037.
   PubMed Web of Science ®Google Scholar
• Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3–22.
   PubMed Web of Science ®Google Scholar
• Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol 2008;181:8677–8687.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 2010;107:1660–1665.
   PubMed Web of Science ®Google Scholar
• Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992;33:626–640.
   PubMed Web of Science ®Google Scholar
• Papas EB, Keay L, Golebiowski B. Estimating a just-noticeable difference for ocular comfort in contact lens wearers. Invest Ophthalmol Vis Sci 2011;52:4390–4394.
   PubMed Web of Science ®Google Scholar
• Papas E, Tilia D, McNally J, de la Jara PL. Ocular discomfort responses after short periods of contact lens wear. Optom Vis Sci 2015;92:665–670.
   PubMed Web of Science ®Google Scholar
• Willcox MD, Zhao Z, Naduvilath T, Lazon de la Jara P. Cytokine changes in tears and relationship to contact lens discomfort. Mol Vis 2015;21:293–305.
   Google Scholar
• Singh RK, Tandon R, Dastidar SG, Ray A. A review on leukotrienes and their receptors with reference to asthma. J Asthma 2013;50:922–931.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Ford-Hutchinson AW, Charleson S, Taudorf E. Detection of leukotriene C4-liked immunoreactivity in tear fluid from subjects challenged with specific allergen. Prostaglandins 1984;27:369–374.
   PubMed Web of Science ®Google Scholar
• Akman A, Irkec M, Orhan M, Erdener U. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis. Ocul Immunol Inflamm 1998;6:179–184.
   PubMed Web of Science ®Google Scholar
• Leonardi A. Allergy and allergic mediators in tears. Exp Eye Res 2013;117:106–117.
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19–26.
   PubMed Web of Science ®Google Scholar
• Profita M, Sala A, Bonanno A, Riccobono L, Siena L, Melis MR, et al. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003;112:709–716.
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Su YC, Chan SC, Ho CK, Feng TC. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy. J Formos Med Assoc 2001;100:241–243.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000;162:878–882.
   PubMed Web of Science ®Google Scholar
• Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008;9:162–176.
   PubMed Web of Science ®Google Scholar
• Ishihara O, Sullivan MH, Elder MG. Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture. Eicosanoids 1991;4:203–207.
   PubMedGoogle Scholar
• Aked DM, Foster SJ. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid. Br J Pharmacol 1987;92:545–552.
   PubMed Web of Science ®Google Scholar